Adherence: A major unmet need. CV Success Zone programme

European Heart Journal, Supplement

Volumn 9, Issue B, 2007, Pages

  Glasspool, John ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Communication; Compliance; Hypertension; Pharmacotherapy

Indexed keywords

EID: 66749159861     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum007     Document Type: Article

References (13)

1. EU. Official Journal C 165, 17 June 1994.
2. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;18:1231-1248.
3. McInnes GT. Hypertension control-an old song resung. Blood Press 2004;13:69-71.
4. Waeber B. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension. Expert Rev Cardiovasc Ther 2003;1:43-50.
5. World Health Organization. 2003; (www.who.int/chronic conditions/adherence report/en/index.html).
6. Chobanian AV, Bakris GL, Black HR, Cushman WE, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program Coordinating Committee. Hypertension 2003;42:1206-1252.
7. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005;12:243-249.
8. Rizzo JA, Abbott TA III, Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ 1996;5:249-265.
9. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994;32:214-226.
10. Hansson L. 'Why don't you do as I tell you?' Compliance and antihypertensive regimens. Int J Clin Pract 2002;56:191-196.
11. Luft FC. STOPPING at the CAPPP of good HOPE. Nephrol Dial Transpl 2000;15:451-452.
12. Long G, Cutler DM, Berndt ER, Royer J, Fournier AA, Sasser A, Cremieux P. The impact of antihypertensive drugs on the number and risk of death, stroke and myocardial infarction in the United States. 2006; NBER Working Paper Series.
13. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000;35:539-543.